gentian violet has been researched along with Angiogenesis, Pathologic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsuda, T; Nakajima, T; Saito, Y; Sakamoto, T | 1 |
Berger, BJ; Kamp, G; Kirkpatrick, CJ; Peters, K; Pröls, F; Schmidt, H; Unger, RE | 1 |
Donato, NJ; Johnson, FM; Saigal, B; Talpaz, M | 1 |
3 other study(ies) available for gentian violet and Angiogenesis, Pathologic
Article | Year |
---|---|
Comparison of magnifying chromoendoscopy and narrow-band imaging in estimation of early colorectal cancer invasion depth: a pilot study.
Topics: Adenocarcinoma; Carcinoma in Situ; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; Coloring Agents; Gentian Violet; Humans; Image Enhancement; Intestinal Mucosa; Lymphatic Metastasis; Microscopy; Neoplasm Invasiveness; Neoplasm Staging; Neovascularization, Pathologic; Observer Variation; Precancerous Conditions; Prognosis; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2011 |
Paradoxical effects of hypoxia-mimicking divalent cobalt ions in human endothelial cells in vitro.
Topics: Cell Line; Cell Proliferation; Cells, Cultured; Cobalt; Coloring Agents; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Gentian Violet; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoenzyme Techniques; In Vitro Techniques; Ions; Ki-67 Antigen; Microscopy, Fluorescence; Neovascularization, Pathologic; Oxygen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Software; Transcription Factors; Vascular Endothelial Growth Factor A | 2005 |
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Crk-Associated Substrate Protein; Dasatinib; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Focal Adhesion Protein-Tyrosine Kinases; G1 Phase; Gentian Violet; Head and Neck Neoplasms; Humans; Immunoprecipitation; Inhibitory Concentration 50; Laminin; Lung Neoplasms; Neoplasm Invasiveness; Neovascularization, Pathologic; Paxillin; Phosphorylation; Protein-Tyrosine Kinases; Proteoglycans; Pyrimidines; Retinoblastoma Protein; S Phase; Signal Transduction; src-Family Kinases; Thiazoles; Time Factors; Trypan Blue | 2005 |